These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21047299)

  • 1. Evaluation of adverse drug event information in US manufacturer labels.
    Harrington CA; Garcia AS; Sircar-Ramsewak F
    Curr Drug Saf; 2011 Feb; 6(1):30-5. PubMed ID: 21047299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse-drug-event data provided by pharmaceutical companies.
    Cudny ME; Graham AS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
    Sonawane KB; Cheng N; Hansen RA
    J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
    Alatawi YM; Hansen RA
    Expert Opin Drug Saf; 2017 Jul; 16(7):761-767. PubMed ID: 28447485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
    Cragg A; Small SS; Lau E; Rowe A; Lau A; Butcher K; Hohl CM
    Drug Saf; 2023 Nov; 46(11):1161-1172. PubMed ID: 37783974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cough and cold medication adverse events after market withdrawal and labeling revision.
    Hampton LM; Nguyen DB; Edwards JR; Budnitz DS
    Pediatrics; 2013 Dec; 132(6):1047-54. PubMed ID: 24218462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?
    Green JL; Hawley JN; Rask KJ
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):31-9. PubMed ID: 17608245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural Networks.
    Dandala B; Joopudi V; Devarakonda M
    Drug Saf; 2019 Jan; 42(1):135-146. PubMed ID: 30649738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.
    de Vries ST; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    Health Qual Life Outcomes; 2014 Aug; 12():103. PubMed ID: 25115618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety information in drug labeling: a comparison of the USA, the UK, and Japan.
    Shimazawa R; Ikeda M
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):306-18. PubMed ID: 23355452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.
    de Vries ST; Mol PG; de Zeeuw D; Haaijer-Ruskamp FM; Denig P
    Drug Saf; 2013 Sep; 36(9):765-77. PubMed ID: 23553447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.
    Moore TJ; Furberg CD; Mattison DR; Cohen MR
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):713-8. PubMed ID: 26861066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in the Veterans Affairs healthcare system: Frequency, severity, and causative medications analyzed by patient age.
    Moore VR; Glassman PA; Au A; Good CB; Leadholm TC; Cunningham FE
    Am J Health Syst Pharm; 2019 Feb; 76(5):312-319. PubMed ID: 30753290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative analysis of adverse events and "overwarning" in drug labeling.
    Duke J; Friedlin J; Ryan P
    Arch Intern Med; 2011 May; 171(10):944-6. PubMed ID: 21606101
    [No Abstract]   [Full Text] [Related]  

  • 17. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():101-115. PubMed ID: 30409335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
    Cheng C; Guglielmo BJ
    Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
    [No Abstract]   [Full Text] [Related]  

  • 19. Detecting Adverse Drug Events: Accuracy and Generalizability.
    Walter SR; Gallego B
    Ther Innov Regul Sci; 2019 Nov; 53(6):795-796. PubMed ID: 30595045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():157-171. PubMed ID: 30409341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.